Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

CLINICAL PATHOLOGY > Transplantation and Immunosuppressive Drugs > Flashcards

Transplantation and Immunosuppressive Drugs Flashcards

1
Q

What is transplantation?

A

Transplantation can be defined as the introduction of biological material (e.g organs, tissue, cells) into an organism

The problem with that is that the immune system has evolved to remove anything that it regards as non-self

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is an autologous transplant?

A

The transplantation from one part of an organism into another part of the same organism

  • You may see an inflammatory response but there wouldn’t be any problems as it is self-transplanted into self
  • E.g skin transplant from one site to another
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a syngeneic transplant?

A

This is where donor material is transplanted into a recipient, however the donor and the recipient are genetically identical

  • These should not generate an immune response as there is no genetic difference between donor + recipient
  • E.g identical twins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is an allogenic transplant?

A

Allogenic transplantation is when a donor donates part of their tissue to a recipient, but they are genetically different.

An example of this would be siblings/ relatives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe Xenogeneic transplants?

A

The transfer of tissue from an organism of one species to another

e.g Pig heart transplant into humans, however this is not common and there have only been a few cases where this happens with success

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are immune responses to transplants caused by?

A

Genetic differences between the donor and recipient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the most important consideration during transplantation?

A

MHC Genes

  • The most important genetic differences are differences between the antigens forming the MHC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where are MHC genes located?

A

On chromosome 6

  • Most diverse region in the genome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is HLA classified?

A

MHC I

  • HLA-A, HLA-B, HLA-C

MHC II

  • HLA-DRA, HLA-DRB, HLA-DPA, HLA-DQA, HLA-DQB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How can we match donor and recipient MHC?

A

Via next generation sequencing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the reasons for transplant rejection?

A

Either

  • MHC protein is foreign
  • Peptide in binding groove is foreign
    • This can result in different rejection mechanisms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is allorecogition?

A

Activation of T cells to react against transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe indirect allorecognition

A

Recipient T cells recognise a self-MHC molecule on a recipient cell with a bound peptide derived from the donor/foreign MHC molecule = T Cell Activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe direct allorecognition

A

Recipient T cells recognise an intact allogenic (unmatched/foreign) MHC molecule expressed by a donor cell = T cell activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Are dead or live donors more succesful for transplants?

A
  • Live donors are more succesful
    • This is because dead organ donors are more sensitive to MHC mismatch
      • Organs from deceased donors are more likely to be in a inflamed condition due to ischaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the types of graft rejection?

A
  • There are three types of graft rejection
    • Hyperacute rejection (pre-exisiting anti-donor Abs bind to antigens on donor tissue)
    • Acute rejection (Direct allorecognition)
    • Chronic rejection (Indirect allorecognition)
17
Q

What is hyperacute rejection?

A

Pre-existing anti-donor antibodies rapidly bind antigens on donor tissue and result in

  • Complement activation
  • Antibody dependant cellular cytotoxicity (Fc receptors on NK cells)
  • Phagocytosis (Fc receptors on macrophages)
18
Q

What is the onset of hyperacute rejection?

A

Within a few hours

19
Q

Which antigens do pre-existing anti-donor antibodies bind to in hyperacute rejection?

A
  • Usually to ABO blood group antigens expressed on endothelial cells of blood vessels
  • MHC I proteins
20
Q

Where is hyperacute rejection most commonly seen?

A

In highly vascularised organs e.g kidney

21
Q

What is the effector mechanism of preexisting anti-donor antibodies in hyperacute rejection?

A
  • Antibodies will bind to ABO antigens expressed on endothelial cells
  • This will lead to complement activation and accumulation of innate immune cells
  • Endothelial damage = platelet accumulation and development of thrombi
  • Tissue can die indirectly from this breakdown in the endothelial cells by ADCC and ADCP
22
Q

What is acute rejection?

A
  • Direct allorecognition of foreign MHC
    • Donor DC’s will migrate to secondary lymphoid tissue where they encounter effector T-cells = MHC mismatch
    • Dendritic cells express both MHC I and MHC II meaning they activate both CD8+ and CD4+ T-cells
    • CTL will increase inflammation and destroy the transplant
23
Q

What is chronic rejection?

A

Indirect allorecognition

  1. Donor cells die
  2. Membrane fragments containing donor MHC are taken up by recipient/ host dendritic cells
  3. Donor MHC is processed into peptides which are presented by host MHC
  4. T cell response is generated to the peptide derived from the processed donor MHC
24
Q

What is the onset of chronic rejection?

A

Can occur months or years after transplant

25
Q

How can we transplant immune cells?

A

Haematopoietic Stem Cell Transfer (HSCT)

  • Stem cells find their way to the bone marrow after infusion and regenerate there where they are cyropreserved with little damage
  • Often autologous (will not cause an immune response)
26
Q

What is the risk of transplanting immune stem cells from a donor to recipient (allogenic)?

A

Graft vs Host Disease (GVHD)

  • Risk of donor immune cells attacking the host
  • Can be lethal
27
Q

How do we prevent graft vs host disease?

A

Removing T-cells from transplant or suppressing their function reduces GVHD

28
Q

Explain a situation where grafting a donor immune system can be beneficial?

A

Graft vs Leukaemia

  • Sometimes mismatch and donor leukocytes are beneficial
  • Cancer cells are derived from self, and the immune system struggles to identify it as a foreign cell
    • However, if you have a donor’s immune system transplanted it will be able to recognise the cancer as foreign and kill them because of the HLA mismatch
29
Q

How can we maintain a non-autolgous transplant?

A

Immunosuppression drugs are essential to maintain a non-autologous transplant

30
Q

What are the phases of treatment to immunosuppression following a transplant?

A
  • Induction (Preventing the build-up of an immune response against transplant organ)
  • Maintenance (will be altering dosage depending on the effectiveness of individual treatment)
  • Rescue (if the immune response mounts towards the tumour)
31
Q

What can immunosuppresant drugs be?

A
  • General immune inhibitors
    • Corticosteroids
  • Cytotoxic
    • Kill proliferating lymphocytes
      • E.g mycophenolic acid, cyclophosphamide, methotrexate
  • Immunosuppressive specific T cells
    • Cyclosporin A, FK506

Using combinations are more effective than single dosage drugs and allows you to reduce the dosage of both drugs and reduce the side effects.

32
Q

What is the course of immunosuppresants

A

Immunosuppressive drugs may need to be maintained indefinitely

33
Q

What is cyclosporin?

A

Cyclosporin will block T-cell proliferation and differentiation

34
Q

What infection can immunosuppressed patients be at risk of?

A

Transplant patients are more susceptible to infection and malignancy

  • Immediate risk of CMV
35
Q

What is the problem with immunosuppressive drugs?

A

They can lead to organ failure

  • Cyclosporin nephrotoxicity in kidney transplant
36
Q

What can be used to help patients that do not respond to immunosuppressive therapy?

A

Faecal material transplant

  • Immunosuppresed patients (e.g cancer patients) can take FMT in order to promote effective anti-cancer immune responses
  • The microbiome particularly of the intestine is involved in adaptive immune responses

CLINICAL PATHOLOGY (52 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions